Latest Europe News

Sco Technology forecasts a record FY26 with revenue up to NZ$296 million and operating EBITDA reaching NZ$36 million, reflecting strong progress on its ambitious Destination 2030 growth plan.

Lindian Resources has acquired 100% ownership of the SARECO rare earths processing plant in Kazakhstan, accelerating its downstream ambitions, while also clarifying regulatory compliance and licence validity at its Kangankunde project in Malawi.

Tabcorp Holdings has agreed to acquire BetMakers Technology Group for approximately $267 million, aiming to accelerate its wagering technology upgrade and expand its global B2B footprint. The deal targets $30 million in cost synergies by Year 2 and expects double-digit EPS accretion by Year 3.

Imricor Medical Systems has ignited its US commercial operations with rapid adoption by top pediatric hospitals, buoyed by FDA pediatric clearances and clinical trial progress.

Krakatoa Resources has locked in $2.4 million through a strategic placement anchored by a $1.8 million investment from a Hong Kong private investor, funding the first 10% acquisition of the Zopkhito Antimony-Gold Project and accelerating its 2026 exploration program.

James Hardie Industries posted a 64% jump in Q1 FY27 net sales to $1.475 billion, powered by the AZEK acquisition and solid organic growth. The company exceeded EBITDA guidance and raised its full-year outlook, targeting robust sales and cash flow growth amid cautious housing market assumptions.

Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.

Neuren Pharmaceuticals saw a record Q2 with DAYBUE net sales hitting US$125 million, driven by strong uptake of the new STIX formulation. The company upgraded its 2026 royalty guidance following Acadia Pharmaceuticals’ sales boost and awaits key regulatory milestones in Europe and Japan.

Memphasys secures exclusive Felix™ commercialisation agreement in Poland, marking its third European market entry with a two-year contract valued at approximately A$350,000.

AoFrio’s revenue fell 21.5% in 1H26, dragged down by a 50.5% plunge in motor sales due to US tariffs, while IoT revenue grew modestly. The company launched new cellular and software platforms, raised NZD 8.9 million, and is expanding into Food Retail, but full-year revenue growth now looks unlikely.

Stakk Ltd's combined pro forma FY2026 revenue with ParaScript has climbed to approximately A$45 million, surpassing earlier forecasts by 9%. Both companies outperformed initial revenue assumptions, setting a stronger baseline ahead of integration benefits.

Vmoto Limited’s 2Q26 sales soared 156% year-on-year with strong international orders and strategic partnerships, including a global MotoGP deal and a joint venture in Thailand.